Search

everythinglearnresearchcommunity

for

Search:↓

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

The document's conclusion cannot be provided because the content is not available.

A rare case of trichothiodystrophy was found with autism, seizures, and mental retardation.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Promising cancer treatments were found, but the manufacturer closed.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

Pulsed Dye Laser effectively treats skin lesions in Rosai–Dorfman Disease.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Most people who volunteered for a health study had medical issues, showing the need for careful screening before trials.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Public health decisions should rely on independent trials, not biased literature.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Baricitinib was effective in treating alopecia areata in two major trials.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.